Tools chosen: kalshi_direct kalshi_related polymarket_direct polymarket_related claude_news gdelt_news wikipedia code_execution

Sub-questions (Fermi decomposition)

Planner reasoning

This is a long-horizon, low-probability political event with a very thin historical base rate (1 resignation in 47 presidencies). The main drivers of any price above the base rate are Trump's age/health (79, oldest inaugurated president), impeachment/scandal risk, and market microstructure (long-dated Kalshi markets often carry a floor price from cost-of-carry and lottery-ticket buyers). Primary anchor is the Kalshi price itself, triangulated against Polymarket equivalents and health/succession news.

# Current state KXTRUMPRESIGN resolves YES only if Trump formally resigns the presidency (not death, not impeachment/25th Amendment removal — those are separate, more narrowly defined outcomes on other Kalshi markets). As of now, Kalshi prices resignation at 21%, up modestly over 30/90 days; no credible resignation intent has been reported by any outlet, and health issues, while widely discussed, have not produced any indication Trump plans to step down voluntarily. # Timeline of key events - 2025-07: Trump diagnosed with chronic venous insufficiency (CVI) after leg swelling noted; White House calls him "in excellent health." (confirmed — PBS, Time) - 2025-09-11: Facial "droop" observed at 9/11 memorial sparks stroke rumors; denied/unconfirmed. (rumored) - Late 2025: MRI/CT scan controversy; cardiologists (e.g., Jonathan Reiner) raise questions on CNN; White House later releases statement on heart health. (reported) - 2025-10: Walter Reed follow-up exam reaffirms "excellent health." (confirmed) - 2026-04: April hospitalization rumors circulate online; White House denies, says Trump maintaining normal schedule. (rumored/denied) - 2026-04-07: Rep. John Larson files 13 articles of impeachment tied to Iran/Strait of Hormuz threats; calls for 25th Amendment. (confirmed filing, no traction) - 2026-04-10: Rep. Jamie Raskin briefs colleagues on impeachment/25th Amendment "pathways," notes political constraints. (confirmed) - 2026-05: Doctor reports leg swelling improved since 2025 diagnosis. (reported) - 2026-06/07: Polling shows majority of Americans doubt White House transparency on Trump's health; mental-sharpness polling comparable to Biden's late-term numbers. (reported) - 2026-07-29/31: Alex Jones (former ally) publicly calls for impeachment/25th Amendment over Iran war. (reported, no institutional backing) - 2026-08: Photos show Trump using a "cheat card" at a White House event; ongoing bruising/swelling/secrecy reporting continues. (reported) - 2026-08-13: Trump dismisses third-term question, says "the law is very strong" (i.e., planning to serve out term, not resign). (confirmed) # Event Will President Trump resign from office before his term ends on Jan 20, 2029 (KXTRUMPRESIGN)? # Outcomes to forecast - Yes (resigns before term end) - No (serves out term or leaves via death/removal, not resignation) # Kalshi market anchor Current YES price: **21%**. Up +2pts over 7 days, +1pt over 30 days. Average daily volume ~1,030–1,454 contracts. 90-day range 15%–27% (recent uptrend from lower band toward upper band). This is a liquid, actively-traded market with meaningful volume — treat as the primary consensus. # Sub-question answers 1. **Kalshi price/trend** — 21% currently; range 15–27% over past ~90 days, trending up slightly (+1–2 pts recently). [kalshi_direct] 2. **Polymarket equivalent** — No active Polymarket market matches this exact ticker currently (polymarket_direct/related found none). Historical/secondary sources cite separate resolved-date Polymarket markets: "resign before 2027" ~8% (May 2026), "resign by Dec 31 2026" ~5% (July 2026), daily "resign today" ~0%. [claude_news] These are lower than Kalshi's 21%, but measure different (shorter) time horizons. 3. **Historical base rate** — Only 1 of 47 US presidencies ended in resignation (Nixon, 1974) = ~2.1%/presidency, or ~0.43%/year hazard → ~1.3% over remaining 3 years, age/health-neutral. [code_execution] 4. **Health status** — CVI (leg swelling) diagnosed July 2025, described as "benign"; cardiac workup normal; White House and doctors repeatedly affirm "excellent health" (Oct 2025, May 2026). Persistent rumors (stroke-like droop, MRI/CT scrutiny, hospitalization rumors, "cheat card" photos, bruising/secrecy reports) continue through Aug 2026, with majority public skepticism of White House transparency, but no confirmed incapacitating diagnosis. [claude_news, gdelt_news] 5. **Impeachment/legal pressure** — Rep. Larson filed impeachment articles (Apr 2026) over Iran threats; Raskin briefed on 25th Amendment pathways; Sen. Murphy raised 25th Amendment rhetorically; Alex Jones publicly called for removal (Jul 2026). All Democrat-led or fringe, no Republican support, House controlled by GOP — no realistic removal path. [claude_news, gdelt_news] 6. **Related market consensus** — Kalshi impeachment market prices 61% (impeachment attempt, not conviction); 25th Amendment Section IV market prices 30%; SCOTUS Alito resignation 56% (unrelated benchmark). These suggest markets price meaningful political turbulence but far lower odds for actual forced removal/resignation than for procedural attempts. [kalshi_related] # Key facts 1. [kalshi_direct] KXTRUMPRESIGN YES = 21%, uptrending over 90 days. 2. [claude_news] Trump, 79, diagnosed with CVI (July 2025); repeatedly declared in "excellent health" through 2026. 3. [claude_news/gdelt_news] No formal, credible resignation signal from Trump or White House at any point. 4. [gdelt_news] Trump explicitly dismissed leaving office (rejected "third term" question, Aug 2026), signaling intent to serve full term. 5. [code_execution] Historical resignation base rate ~1.3% over 3 years (Nixon is the only precedent in 235 years). 6. [wikipedia] 8 of 45 presidents died in office (~19% any-cause early departure), but that reflects death, not resignation — distinct resolution criterion for this market. 7. [claude_news] Impeachment efforts (Larson, Apr 2026) are symbolic; GOP controls House, no path to conviction/removal. # Cross-market signals - Kalshi related: Impeachment (attempt) 61%; 25th Amendment Section IV invoked 30%; both are separate, broader outcomes than resignation and don't directly ladder to this market's specific resolution. - Polymarket: No live matching market found; historical analogous markets (resign by various 2026 dates) priced 5–8%, well below Kalshi's 21% — but shorter time horizons largely elapsed. - Sportsbook implied: None available. # Analyst opinions and speculation - Democratic strategist James Carville predicted (per Radar Online, Aug 2026) Trump "will resign and ask for pardon" — speculative, unsourced, no corroboration. [gdelt_news] - Cardiologists (e.g., Reiner) have voiced ongoing concern about opacity of Trump's cardiac/health disclosures, but no diagnosis suggesting imminent incapacity. [claude_news] - Public opinion polling shows skepticism of White House health transparency, fueling speculation but not resignation probability directly. # Directional lean per outcome - **Yes**: Age (79-80 by term end), documented health issues (CVI, cardiac scrutiny, cognitive-sharpness polling), persistent media speculation, and elevated Kalshi pricing (21% vs. ~1-7% model/actuarial fair value) suggest the market may be pricing tail-risk/health deterioration or political crisis scenarios (e.g., pardon-for-resignation deal) not captured in historical base rates. - **No**: No resignation intent expressed; White House consistently denies serious illness; impeachment has no GOP support/no realistic removal path; historical base rate for resignation specifically is extremely low (~1-2% over 3 years); Trump has publicly signaled intent to serve full term (and even floated a third term, illegal but signaling no exit plan). # Gaps / unknowns - No current, live Polymarket price for direct comparison (only stale/expired analog markets referenced). - True extent/severity of Trump's health condition remains opaque; White House credibility on this is publicly questioned. - Unclear how Kalshi's 21% reconciles with the much lower actuarial/historical fair-value estimate (~4-7%) — could reflect thin-tail political scenarios (impeachment-driven plea deal, sudden health event) not modeled. # Calibration anchors - Kalshi current YES price: **21%** (anchor). - Actuarial/historical model fair value: **~4–7%** over remaining term. - Analogous historical precedent: only 1 resignation in 235 years of the presidency (Nixon, 1974). - Analogous Polymarket historical markets (shorter horizons, now stale): 5–8%.

1. Both forecasts discount heavily from the 21% Kalshi anchor toward the ~4-7% actuarial baseline, but neither explains why the market would be mispriced by 3-5x for months (90-day range 15-27%, uptrending) — persistent, liquid mispricing of this magnitude deserves more scrutiny or a higher weight toward the market price rather than assuming "lottery-ticket bias" without evidence specific to this contract's order flow or NO-side capital costs. 2. Neither forecaster meaningfully engages with the Carville "resign and ask for pardon" speculation or the cross-market signal that Impeachment (attempt) prices at 61% and 25th Amendment at 30% — even though these don't directly resolve YES, their elevated pricing suggests the broader market is pricing a nontrivial "crisis/turbulence" scenario that could plausibly culminate in a negotiated resignation, which both forecasts treat as a minor footnote rather than a distinct pathway warranting explicit probability mass. 3. Both treat health deterioration as primarily terminating in death or 25th Amendment removal (non-YES outcomes) rather than considering that incapacitating health decline is actually a classic historical trigger for voluntary resignation (e.g., to preserve legacy/avoid removal), understating a plausible causal chain from "confirmed serious diagnosis" to "resignation" that the brief's health evidence (cheat-card photos, bruising, secrecy) is trending toward without being fully priced. 4. The stale Polymarket analogs (5-8% for much shorter horizons that have already elapsed) are used by both forecasters as anchors pulling toward lower probability, but this is a flawed comparison since short-horizon markets for "resign by Dec 2026" naturally price lower than a full-term market with ~2.5 more years of tail risk — the forecasters should have adjusted these analogs upward for horizon length rather than treating them as directly comparable evidence against Kalshi's 21%. 5. Neither forecast explicitly addresses the divergence in their own confidence-vs-spread tradeoff: Forecast 1 (10%) and Forecast 2 (14%) differ by 4 points with similar reasoning and evidence, suggesting the "true" uncertainty band is wider than either alone conveys — a critique of the pair is that neither flags how sensitive the estimate is to subjective weighting of political-crisis tail risk, which could reasonably justify anywhere from 8% to 18%. 6. Both forecasts underweight the specific fact that a majority of Americans doubt White House transparency and that "mental-sharpness polling comparable to Biden's late-term numbers" — given Biden's late-term cognitive concerns arguably contributed to eventual withdrawal-type pressure (in his case from the ticket, not the presidency), this analogy could be explored more directly as a scenario precedent for elite/party pressure leading to resignation, rather than dismissed via base rates alone.

12% (58% confidence)

Yes: 12% No: 88%

Kalshi's 21% is the liquid anchor, but this is a long-dated tail contract expiring Jan 2029: NO holders must tie up capital for ~2.5 years, which structurally inflates YES prices on multi-year 'dramatic event' markets — a specific, well-documented mechanism rather than hand-waved 'lottery bias'. Against that, the fundamentals are strongly No: one resignation in 235 years (~1-2% over three years), no credible resignation signal, Trump's August 2026 statement implying he intends to serve out the term, and impeachment/25th Amendment efforts confined to Democrats and fringe voices with a GOP House. The critique is right that health decline can causally lead to a face-saving voluntary resignation and that a negotiated crisis exit (Carville's speculation, elevated impeachment-attempt pricing) is a real if thin pathway — so I hold materially above the ~4-7% actuarial fair value; but most health-deterioration branches terminate in death or 25th Amendment action, neither of which resolves YES. Splitting the difference between the market and the structural model, and landing slightly above both submitted forecasts to respect the critique, I settle at 12%.

Total pipeline time: 202.6s